Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DONANEMAB-AZBT for Dementia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 25 adverse event reports in the FDA FAERS database where DONANEMAB-AZBT was used for Dementia.

Most Reported Side Effects for DONANEMAB-AZBT

Side Effect Reports % Deaths Hosp.
Amyloid related imaging abnormality-oedema/effusion 185 18.2% 2 20
Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits 139 13.7% 1 12
Headache 111 10.9% 1 16
Infusion related reaction 97 9.5% 1 11
Amyloid related imaging abnormalities 80 7.9% 4 13
Flushing 68 6.7% 0 7
Cerebral haemorrhage 54 5.3% 4 14
Dizziness 48 4.7% 1 9
Nausea 44 4.3% 0 4
Cerebral microhaemorrhage 41 4.0% 0 1
Confusional state 40 3.9% 1 9
Dyspnoea 39 3.8% 0 8
Chills 38 3.7% 0 4
Erythema 34 3.3% 0 4
Blood pressure increased 33 3.2% 0 6

Other Indications for DONANEMAB-AZBT

Product used for unknown indication (603) Dementia alzheimer's type (347) Cognitive disorder (96)

Other Drugs Used for Dementia

DONEPEZIL (1,350) RIVASTIGMINE (887) MEMANTINE (812) PIMAVANSERIN (526) GALANTAMINE (406) QUETIAPINE (366) RISPERIDONE (294) GALANTAMINE HYDROBROMIDE (291) BREXPIPRAZOLE (160) OLANZAPINE (151)

Related Pages

DONANEMAB-AZBT Full Profile All Dementia Drugs DONANEMAB-AZBT Demographics DONANEMAB-AZBT Timeline